Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Pasini

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Breast Cancer Research and Treatment|October 9, 2003
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutationPaolo Aretini, Emma D'Andrea, Barbara Pasini, et al.
British Journal of Cancer|June 26, 2008
Rapid progression of prostate cancer in men with a BRCA2 mutationS A Narod, S Neuhausen, G Vichodez, et al.
Journal of the National Cancer Institute|December 5, 2002
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersSteven A Narod, Marie-Pierre Dubé, Jan Klijn, et al.
The New England Journal of Medicine|December 23, 2011
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancersAlireza Heravi-Moussavi, Michael S Anglesio, S-W Grace Cheng, et al.
Breast Cancer Research and Treatment|January 25, 2007
Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Henry T Lynch, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variantsHongyan Li, Christoph Engel, Miguel de la Hoya, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 7, 2022
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variantsHongyan Li, Christoph Engel, Miguel de la Hoya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer RiskLenka Stolarova, Petra Kleiblova, Petra Zemankova, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 7, 2011
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, et al.
Breast Cancer Research : BCR|April 7, 2011
Exploring the link between MORF4L1 and risk of breast cancerGriselda Martrat, Christopher M Maxwell, Emiko Tominaga, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Breast Cancer Research and Treatment|October 9, 2003
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutationPaolo Aretini, Emma D'Andrea, Barbara Pasini, et al.
British Journal of Cancer|June 26, 2008
Rapid progression of prostate cancer in men with a BRCA2 mutationS A Narod, S Neuhausen, G Vichodez, et al.
Journal of the National Cancer Institute|December 5, 2002
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersSteven A Narod, Marie-Pierre Dubé, Jan Klijn, et al.
The New England Journal of Medicine|December 23, 2011
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancersAlireza Heravi-Moussavi, Michael S Anglesio, S-W Grace Cheng, et al.
Breast Cancer Research and Treatment|January 25, 2007
Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Henry T Lynch, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variantsHongyan Li, Christoph Engel, Miguel de la Hoya, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 7, 2022
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variantsHongyan Li, Christoph Engel, Miguel de la Hoya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer RiskLenka Stolarova, Petra Kleiblova, Petra Zemankova, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 7, 2011
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, et al.
Breast Cancer Research : BCR|April 7, 2011
Exploring the link between MORF4L1 and risk of breast cancerGriselda Martrat, Christopher M Maxwell, Emiko Tominaga, et al.
Pageof 10